Suppr超能文献

[慢性多关节炎的全身淋巴照射——一种新的治疗理念]

[Total lymphoid irradiation in chronic polyarthritis--a new therapeutic concept].

作者信息

Herbst M, Fritz H, Nüsslein H G, Manger B J, Kalden J R, Sauer R

出版信息

Strahlenther Onkol. 1986 Jan;162(1):25-30.

PMID:3945916
Abstract

Eleven patients with refractory rheumatoid arthritis were submitted to a total lymphoid irradiation up to a dose of 20 Gy. A constant improvement of clinical symptoms was observed in four out of the eleven patients already during the treatment and in the other patients not later than two months after. The frequency of attacks decreased and the number of joints involved in the attack was reduced. Morning rigidity and joint swellings decreased. One patient developed joint empyemas 4 and 26 months after the treatment. Four patients died in the meantime. In two patients the cause of death were renal insufficiency and a postoperative cardiogenic shock associated with generalized amyloidosis. The third patient died because of a toxically induced left cardiac decompensation with sepsis that could not be controlled by antibiotic drugs and multiple joint empyemas. The fourth patient developed an abscess after surgical treatment of a Kaposi syndrome. She died three months later from acute left cardiac decompensation. The therapy induced a lymphocytopenia with decrease of T helper lymphocytes and unchanged number of T suppressor lymphocytes. The constant therapy results of total lymphoid irradiation in primary chronic polyarthritis is probably due to this modification in the immune regulation.

摘要

11例难治性类风湿关节炎患者接受了总量达20 Gy的全身淋巴照射。11例患者中有4例在治疗期间临床症状即持续改善,其他患者在治疗后2个月内也出现改善。发作频率降低,发作时累及的关节数量减少。晨僵和关节肿胀减轻。1例患者在治疗后4个月和26个月发生关节积脓。在此期间有4例患者死亡。2例患者的死因是肾功能不全以及与全身性淀粉样变性相关的术后心源性休克。第3例患者死于毒性诱发的左心衰竭伴败血症,抗生素无法控制,且伴有多处关节积脓。第4例患者在卡波西肉瘤手术治疗后出现脓肿。3个月后死于急性左心衰竭。该疗法导致淋巴细胞减少,辅助性T淋巴细胞数量减少,抑制性T淋巴细胞数量未变。全身淋巴照射对原发性慢性多关节炎的持续治疗效果可能归因于免疫调节的这种改变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验